NICE TA514 - regorafenib for previously treated advanced hepatocellular carcinoma. (Decision date - April 2018)
RED:
NICE TA488 - for previously treated unresectable or metastatic gastrointestinal stromal tumours. (Decision date - December 2017)
NICE TA555 - previously treated advanced hepatocellular carcinoma. (Decision date - February 2019)
NICE TA866 - for previously treated metastatic colorectal cancer. (Decision date - March 2023)
Do Not Prescribe (DNP) Drug Classifications
6: Have NICE guidance that recommends they should not be used
Red Drug Classifications
1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
